Mati Therapeutics
PrivateLast Round
Seed Round
Jul 2, 2026
Total Funding Raised
$12.05M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Mati Therapeutics is a healthcare company developing a non-invasive sustained drug delivery platform, the Evolute® Punctal Plug Delivery System, to treat ocular diseases such as glaucoma.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mati Therapeutics Comparables
Compare Mati Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MediPrint Ophthalmics | 83% | |
| INEYE THERAPEUTICS S.A. | 82% | |
| Ocular Therapeutix Inc | 80% |
Mati Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jul 2, 2026 | ||||
| Series A | Oct 8, 2025 | ||||
| VC Round | Apr 8, 2013 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 123% MoM, reaching 2.1K.
- Jul 2, 2026
Raised $2.65M in a Seed Round.
Mati Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Mati Therapeutics's valuation, stock price, and market status.
Is Mati Therapeutics a public or private company?
Mati Therapeutics is a private company.
What is the current stock price of Mati Therapeutics?
Mati Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Mati Therapeutics worth (valuation)?
Valuation information for Mati Therapeutics is not publicly available.
Can I buy Mati Therapeutics stock?
Mati Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Mati Therapeutics's last funding round?
Mati Therapeutics's most recent funding round was Seed Round on July 2, 2026.
Who are the main investors in Mati Therapeutics?
Investor information for Mati Therapeutics is not publicly disclosed.
Will Mati Therapeutics IPO soon?
No public IPO plans have been announced for Mati Therapeutics.
How can I track Mati Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mati Therapeutics's secondary market activity and sign up for updates.